Rating Change
Goldman Sachs analysts initiated coverage on Elanco Animal Health Incorporated (NYSE:ELAN) with a rating of Buy on October 16, 2026.
new coverageNYSE:ELAN
Goldman Sachs Initiates Coverage on Elanco Animal Health Incorporated (ELAN) with Buy
Goldman Sachs analysts initiated coverage on Elanco Animal Health Incorporated (NYSE:ELAN) with a rating of Buy on October 16, 2026.
At publication ·
What changed
Elanco Animal Health Incorporated (NYSE:ELAN) · new coverage
- Firm
- Goldman Sachs
- Rating
- Buy
- Price at event
- $23.55
- Market capitalization
- $10.6B
At a glance
Key takeaways
- Goldman Sachs initiated Buy coverage on Elanco Animal Health (ELAN) on October 16, 2026, as the stock trades at $23.55 with a $10.6B market capitalization.
Market Context
Elanco Animal Health Incorporated operates in the Healthcare sector. The stock currently trades at $23.55 with a market capitalization of $10.6B. The stock has gained 9.9% over the past 52 weeks.
Analyst coverage from Goldman Sachs provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Elanco Animal Health Incorporated.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Elanco Animal Health Incorporated
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 16, 2026 | Goldman Sachs | Buy | N/A |
| Aug 06, 2026 | Keybanc | Overweight | N/A |
| Aug 06, 2026 | UBS | Buy | N/A |
| Jul 22, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Jun 18, 2026 | TD Cowen | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ELAN Stock Page
Frequently Asked Questions
What does the Buy rating mean for ELAN?
A rating of Buy from Goldman Sachs reflects the analyst's outlook on Elanco Animal Health Incorporated (NYSE:ELAN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ELAN forecast page.